GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cargo Therapeutics Inc (NAS:CRGX) » Definitions » SpecialCharges

CRGX (Cargo Therapeutics) SpecialCharges


View and export this data going back to 2023. Start your Free Trial

What is Cargo Therapeutics SpecialCharges?

Special Charges only applies to banks.


Cargo Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
835 Industrial Road, Suite 400, San Carlos, CA, USA, 94070
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.